The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
Background and purpose: With currently available techniques, the prediction of pathologic complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma ratio (TSR) has proven to be a predictor of survival for several types of cancer, including esophageal. The aim of this st...
| Prif Awduron: | , , , , , , , , , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
Elsevier
2020-01-01
|
| Cyfres: | Clinical and Translational Radiation Oncology |
| Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S2405630819301107 |